规格 : 每粒装0.32g剂型 : 胶囊剂批准日期 : 2010-8-16批准文号 : 国药准字Z20050112药品类型 : 中药
桂龙咳喘宁胶囊 Guilong Kechuan Capsule
Method:Randomized controlled trial using research methods will be divided into 68 cases of patients with the treatment group 35 cases and 33 cases of the control group,treatment group to Pingchuan No. Ⅰ,the control group to Guilong Kechuanning capsule.
方法:采用随机对照试验研究方法将68例患者分为治疗组35例和对照组33例,治疗组予平喘Ⅰ号,对照组予桂龙咳喘宁胶囊。
参考来源 - 平喘Ⅰ号治疗支气管哮喘35例临床观察及对血清TNF·2,447,543篇论文数据，部分数据来源于NoteExpress
目的：探讨咳喘宁胶囊对实验性慢性支气管炎治疗作用的内在机制。
Objective: To make research on the internal mechanism of treating experimental chronic bronchitis with Kechuanning capsules.
目的：探讨咳喘宁胶囊对实验性慢性支气管炎治疗作用的内在机制。
To make research on the internal mechanism of treating experimental chronic bronchitis with Kechuanning Capsule.
结论：慢支咳喘宁胶囊可降低IL - 4含量，控制慢性炎症反应。
Conclusion: Manzhi Kechuanning Capsules can control chronic inflammatory reaction by reducing the content of IL-4.
应用推荐